Back to Capital International Investors

ABT
Showing 8 of 30 quarters

Position history for Capital International Investors's holdings in ABBOTT LABORATORIES

Capital International Investors holds 37.5M shares of ABT (ABBOTT LABORATORIES), worth $3.8B as of 2026-Q1. The position was decreased (-40.7% shares). ABT represents 0.9% of Capital International Investors's portfolio.

Current Value

$3.8B

Current Shares

37.5M

Total Value Change

-$3.6B

Total Shares Change

-34.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
37.5M
-40.7%
$3.8B0.9%$113.61
0
2025-Q4
Increased
63.2M
+2.6%
$7.9B1.2%$125.15
52
2025-Q3
Increased
61.6M
+2.5%
$8.3B1.3%$131.85
51
2025-Q2
Decreased
60.1M
-10.0%
$8.2B1.4%$132.52
0
2025-Q1
Decreased
66.8M
-1.7%
$8.9B1.7%$128.41
0
2024-Q4
Increased
68M
+3.4%
$7.7B1.4%$110.14
52
2024-Q3
Decreased
65.7M
-8.4%
$7.5B1.4%$109.27
0
2024-Q2
Increased
71.8M
+2.3%
$7.5B1.5%$100.45
51

Other major holders of ABT: VANGUARD GROUP INC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used